Metabolomics for hematologic malignancies: Advances and perspective

被引:0
|
作者
Li, Xinglan [1 ]
Xu, Mengyu [1 ]
Chen, Yanying [2 ]
Zhai, Yongqing [3 ]
Li, Junhong [1 ]
Zhang, Ning [4 ]
Yin, Jiawei [5 ,6 ,7 ]
Wang, Lijuan [5 ,6 ,7 ,8 ]
机构
[1] Shandong Second Med Univ, Linyi Peoples Hosp, Linyi, Peoples R China
[2] Linyi Peoples Hosp, Hematol Lab, Linyi, Peoples R China
[3] Linyi Peoples Hosp, Dept Orthoped, Linyi, Peoples R China
[4] Linyi Peoples Hosp, Dept Anesthesiol, Linyi, Peoples R China
[5] Linyi Peoples Hosp, Cent Lab, Linyi, Peoples R China
[6] Key Lab Tumor Biol, Linyi, Peoples R China
[7] Xuzhou Med Univ, Key Lab Translat Oncol, Xuzhou, Peoples R China
[8] Linyi Peoples Hosp, Dept Hematol, Linyi, Peoples R China
关键词
amino acid metabolism; glucose metabolism; leukemia; lipid metabolism; lymphoma; myeloma; ACUTE MYELOID-LEUKEMIA; B-CELL LYMPHOMA; METABOLISM; SERUM; MICROENVIRONMENT; CHROMATOGRAPHY; PROLIFERATION; BIOMARKERS; SIGNATURE; RESISTANT;
D O I
10.1097/MD.0000000000039782
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With the use of advanced technology, metabolomics allows for a thorough examination of metabolites and other small molecules found in biological specimens, blood, and tissues. In recent years, metabolomics has been recognized that is closely related to the development of malignancies in the hematological system. Alterations in metabolomic pathways and networks are important in the pathogenesis of hematologic malignancies and can also provide a theoretical basis for early diagnosis, efficacy evaluation, accurate staging, and individualized targeted therapy. In this review, we summarize the progress of metabolomics, including glucose metabolism, amino acid metabolism, and lipid metabolism in lymphoma, myeloma, and leukemia through specific mechanisms and pathways. The research of metabolomics gives a new insight and provides therapeutic targets for the treatment of patients with hematologic malignancies.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] ADVANCES IN DIAGNOSIS OF HEMATOLOGIC MALIGNANCIES
    WALDMANN, TA
    HOSPITAL PRACTICE, 1986, 21 (01): : 69 - 77
  • [2] Encouraging Advances in Hematologic Malignancies
    Hennessy, Mike, Sr.
    ONCOLOGY-NEW YORK, 2021, 35 (01): : 6 - 6
  • [3] The Research Advances of Aptamers in Hematologic Malignancies
    Liao, Yongkang
    Xiong, Shijun
    Ur Rehman, Zaid
    He, Xiaoli
    Peng, Hongling
    Liu, Jing
    Sun, Shuming
    CANCERS, 2023, 15 (01)
  • [4] Serum NMR metabolomics in distinct subtypes of hematologic malignancies
    Gul, Ayse Zehra
    Selek, Sahabettin
    Bekiroglu, Somer
    Demirel, Metin
    Cakir, Fatma Betul
    Uyanik, Bulent
    EXPERIMENTAL HEMATOLOGY, 2025, 143
  • [5] Advances in Management for Older Adults With Hematologic Malignancies
    Rosko, Ashley E.
    Cordoba, Raul
    Abel, Gregory
    Artz, Andrew
    Loh, Kah Poh
    Klepin, Heidi D.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (19) : 2102 - +
  • [6] Advances in the treatment of hematologic malignancies using immunoconjugates
    Palanca-Wessels, Maria Corinna
    Press, Oliver W.
    BLOOD, 2014, 123 (15) : 2293 - 2301
  • [7] Advances in CAR T Therapy for Hematologic Malignancies
    Freyer, Craig W.
    Porter, David L.
    PHARMACOTHERAPY, 2020, 40 (08): : 741 - 755
  • [8] Epigenomic insights and computational advances in hematologic malignancies
    Carolyn Lauzon-Young
    Ananilia Silva
    Bekim Sadikovic
    Molecular Cytogenetics, 18 (1)
  • [9] Advances in immunotherapy of hematologic malignancies: Cellular and humoral approaches
    Jurcic, JG
    Cathcart, K
    Pinilla-Ibarz, J
    Scheinberg, DA
    CURRENT OPINION IN HEMATOLOGY, 2000, 7 (04) : 247 - 254
  • [10] Advances in haploidentical stem cell transplantation for hematologic malignancies
    Montoro, Juan
    Sanz, Jaime
    Sanz, Guillermo F.
    Sanz, Miguel A.
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1766 - 1775